Bone metastasis as an independent prognostic factor for survival in patients with advanced melanoma treated with immune checkpoint blockade.

Marcos Rezende Teixeira,Milton Jos De Barros E Silva,Natasha Carvalho Pandolfi,Vinícius Fernando Calsavara,Thiago Bueno Oliveira,Monique Celeste Tavares,José Augusto Rinck,Daniel Garcia,Joao Paulo Sn Lima,João Pedreira Duprat

Bone metastasis as an independent prognostic factor for survival in patients with advanced melanoma treated with immune checkpoint blockade.

2020

Marcos Rezende Teixeira
Milton Jos De Barros E Silva
Natasha Carvalho Pandolfi
Vinícius Fernando Calsavara
Thiago Bueno Oliveira
Monique Celeste Tavares
José Augusto Rinck
Daniel Garcia
Joao Paulo Sn Lima
João Pedreira Duprat

e22045Background: Immune checkpoint blockade (ICB) has changed the natural history advanced melanoma (AM) with response rates about 40% and overall survival in 5 years of more than 30%. Interesting...

Keywords:

Oncology
Blockade
prognostic factor
advanced melanoma
Bone metastasis
in patient
Internal medicine
Pathology
Medicine
Immune checkpoint

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations